Human papillomavirus disease in GATA2 deficiency: a genetic predisposition to HPV-associated female anogenital malignancy

Females with <i>GATA2</i> haploinsufficiency exhibit a heightened risk of recurrent, multifocal anogenital HSIL requiring frequent surveillance and multiple treatments. <i>GATA2</i> haploinsufficiency must be considered in a female with extensive, multifocal genital HSIL unresponsive to multiple surgeries. This population may benefit from early intervention like HSCT accompanied by continued, enhanced surveillance and treatment by gynecologic oncologists and gynecologists in those with anogenital HPV disease.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2024-08-29
DOI
https://doi.org/10.3389/fimmu.2024.1445711
Citations
4
Primary Topic
Metastasis and carcinoma case studies
Type
article
Field-Weighted Citation Impact
1.68

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Human papillomavirus disease in GATA2 deficiency: a genetic predisposition to HPV-associated female anogenital malignancy

Alison A. McBride, Edward W. Cowen, Heidi H. Kong, Koenraad Van Doorslaer et al.
4 citations
Frontiers in Immunology
Metastasis and carcinoma case studies
1.68
article

Human papillomavirus disease in GATA2 deficiency: a genetic predisposition to HPV-associated female anogenital malignancy

Alison A. McBride, Edward W. Cowen, Heidi H. Kong, Koenraad Van Doorslaer, Dennis D. Hickstein, Dominique C. Pichard, Melissa A. Merideth, Steven M. Holland, Ehren K. Dancy, Pamela Stratton, Noemi Salmeri, Theo Heller, Christa S. Zerbe, Beatriz E. Marciano, Mark Parta, Marybeth S. Hughes
article en
4 citations

Abstract

Females with <i>GATA2</i> haploinsufficiency exhibit a heightened risk of recurrent, multifocal anogenital HSIL requiring frequent surveillance and multiple treatments. <i>GATA2</i> haploinsufficiency must be considered in a female with extensive, multifocal genital HSIL unresponsive to multiple surgeries. This population may benefit from early intervention like HSCT accompanied by continued, enhanced surveillance and treatment by gynecologic oncologists and gynecologists in those with anogenital HPV disease.

Frontiers in ImmunologyVol. 15
National Institutes of Health (US), University of Arizona (US), Vita-Salute San Raffaele University (IT), Eastern Virginia Medical School (US), National Institute of Arthritis and Musculoskeletal and Skin Diseases (US), National Human Genome Research Institute (US), National Institute of Diabetes and Digestive and Kidney Diseases (US), National Institute of Neurological Disorders and Stroke (US), National Institute of Allergy and Infectious Diseases (US), National Cancer Institute (US), National Center for Advancing Translational Sciences (US), Center for Cancer Research (US), Istituti di Ricovero e Cura a Carattere Scientifico (IT), National Institutes of Health Clinical Center (US), University of Pennsylvania (US)
National Institutes of Health, National Cancer Institute, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, NIH Clinical Center, National Center for Advancing Translational Sciences
Good health and well-being
Openalex Percentile: Top 15%
Metastasis and carcinoma case studies
1.68
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.